GlassScriptPhysician profile
Sarah C Lex
NPI 1821822347
$1,190.37
in general payments reported to CMS, 2019-2025
21 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $109 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $172.99 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $166.07 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $143.63 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $99.61 | 2024-2025 | Rexulti |
| Lilly USA, LLC | $85.60 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $84.35 | 2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $70.78 | 2025 | |
| Dexcom, INC. | $50.84 | 2024-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $37.92 | 2025 | Trelegy Ellipta, Arexvy |
| Vanda Pharmaceuticals INC. | $37.88 | 2025 | Fanapt |
| Lundbeck LLC | $34.17 | 2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $28.61 | 2025 | Qelbree |
| Astellas Pharma US INC | $26.08 | 2025 | Veozah |
| Tonix Medicines, INC. | $22.04 | 2025 | Tonmya |
| Axsome Therapeutics, INC. | $21.27 | 2025 | Auvelity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20.13 | 2025 | Nexplanon |
| Cranial Technologies, INC | $19.45 | 2025 | Doc Band |
| Eisai INC. | $18.78 | 2024 | |
| Exact Sciences Corporation | $17.31 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $16.46 | 2025 | |
| Collegium Pharmaceutical, INC. | $16.40 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Lex listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.